Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch.

Johnston, Victoria; Cohen, Karen; Wiesner, Lubbe; Morris, Lynn; Ledwaba, Johanna; Fielding, Katherine L; Charalambous, Salome; Churchyard, Gavin; Phillips, Andrew; Grant, Alison D; (2013) Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch. The Journal of infectious diseases, 209 (5). pp. 711-720. ISSN 0022-1899 DOI: https://doi.org/10.1093/infdis/jit411

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/infdis/jit411

Abstract

Share

Download

Filename: J Infect Dis.-2013-Johnston-infdis_jit411.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar